Graham Capital Management L.P. Has $2.28 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Graham Capital Management L.P. increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 6.0% in the 4th quarter, Holdings Channel reports. The firm owned 24,797 shares of the medical device company’s stock after purchasing an additional 1,409 shares during the period. Graham Capital Management L.P.’s holdings in Cooper Companies were worth $2,280,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COO. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the 4th quarter worth approximately $33,000. OFI Invest Asset Management bought a new position in Cooper Companies in the 4th quarter worth approximately $34,000. New Age Alpha Advisors LLC bought a new position in Cooper Companies in the 4th quarter worth approximately $38,000. Covestor Ltd increased its position in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after buying an additional 120 shares during the period. Finally, West Financial Advisors LLC bought a new position in Cooper Companies in the 4th quarter worth approximately $49,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have commented on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. BNP Paribas raised Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Finally, Robert W. Baird lowered their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Stock Performance

COO opened at $82.27 on Monday. The stock has a market cap of $16.45 billion, a PE ratio of 42.19, a P/E/G ratio of 2.25 and a beta of 1.08. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38. The stock’s 50 day simple moving average is $80.54 and its 200-day simple moving average is $90.81.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.